The Race for a Bundibugyo Ebolavirus Vaccine

About this episode:  

Vaccines for the Zaire ebolavirus have been licensed since 2019, but no such treatment exists for the current outbreak of Bundibugyo in the Democratic Republic of the Congo. In this episode: Anna Durbin, director of the Johns Hopkins Center for Immunization Research, introduces listeners to three candidate vaccines and discusses the hurdles to deploying new treatments. 

Guest: 

Dr. Anna Durbin is a professor of International Health and the director of the Johns Hopkins Center for Immunization Research. 

Host: 

Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs. 

Show links and related content: 

• Three Ebola vaccines in development amid growing outbreak fears—BBC 

• USAID's closure led to 'entirely preventable' deaths, latest Ebola outbreak: House Dem report—The Hill 

• HHS confirms Americans with high-risk Ebola exposures will have access to experimental therapy—STAT 

• Regeneron's Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak—Regeneron 

• What Will It Take to Contain the Central Africa Ebola Outbreak?—Johns Hopkins Bloomberg School of Public Health 

• The Use of Investigational Drugs in an Outbreak: Separating Science and Politics With Hydroxychloroquine and COVID-19—Public Health On Call (May 2020)

Transcript information:

Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed cap